| Investors

Are you seeking investment opportunities in the dynamic and transformative field of healthcare innovation? Streasure4Health presents an unparalleled opportunity to join a pioneering company at the forefront of addressing chronic fatigue, with Long Covid Syndrome, Myalgic Encephalomyelitis /Chronic Fatiue Syndrome (ME/CFS) as our first market segment.
Discover
how your investment can drive positive change and make a tangible impact on
global health.
| Why Invest in Streasure4Health?
- Cutting-Edge Research: Streasure4Health is committed to groundbreaking research aimed at understanding and addressing chronic fatigue, a highly debilitating condition of numerous indications.
- Innovative Solutions: Our team is developing scalable diagnostic solutions to accurately diagnose and monitor chronic, paving the way for more effective treatment and management strategies.
- Global Impact: By investing in Streasure4Health, you have the opportunity to contribute to improving the lives of millions worldwide who are affected by metabolic stress and debilitating chronic fatigue.
| Chronic fatigue: huge problem
Chronic fatigue is a huge problem for 4 reasons:
- Large population: 250M patient worldwide across multiple indications (LongCovid, ME/CFS, Fibromyalgia, cancer, PTSD), yearly 10M new patients, societal costs €1.5T; Long Covid: worldwide 65M patients.
- Mental and Physical fatigue: patients have one or both
- Large severity range: from less work/social activity to fully bedbound
- wrong treatment: existing treatments contribute to development of Post-exertional malaise (PEM), worsening patient's quality of life.
Clinicians lack an easy and reliable test that objectively measures severity, mental and physical resilience to guide therapy.
| Solution
- With our patented technology, we develop a test/sensor solving the medical need of clinicians
- Based on customer-prioritized features, our test outcompetes other assays
- Large customer traction (clinicians, companies, patients)
- Strong product-market fit of 69%
A diagnosis costs on average € 30.000, but
gives no clue on a proper treatment. We can replace this by a cheaper and
faster test, also empowering clinicians
to identify and prescribe patient's specific therapies.
| A huge investment opportunity
- TAM/SAM/SOM Long-Covid: €20B/€375M/€9M
- Total Investment requested before Go-to-Market (G2M): €1.3M
- Initial 'investment' requested: Letter-of-intent as first investor following a €450k non-dilutive loan (VFF)
- Expected Go-to-Market: 2-years
- Large expansion opportunities in other (non-IVD) market segments: TAM of €7T
| Invest in the Future of Healthcare
We seek socially-oriented investors with expertise and network in Healthcare/Medtech industry, involved and enthousiastic to our cause.
Seize the opportunity to invest in Streasure4Health and be part of a transformative journey that is reshaping the healthcare landscape. Contact us today to learn more about how you can become a valued investor and partner in our mission to revolutionize healthcare for the betterment of society.
Together, let's build a healthier future. Invest in Streasure4Health today.
Join us creating a world without chronic fatigue
Join us to improve the health of many of us